The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

A new bipartisan bill would end the coverage gap for dementia screening, allowing early diagnosis when treatments are most ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...

A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

ATLANTA — The Georgia Chapter of the Alzheimer’s Association released some holiday gift ideas for loved ones living with the ...